Covaxin

India has approved two COVID-19 vaccines —  Serum Institute of India’s ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ — for emergency restricted use, regulatory body DCGI said on Sunday. Both vaccines have …

The recommendation for Bharat Biotech’s vaccine came a day after the COVID-19 expert panel cleared the Serum Institute of India’s emergency use authorisation application for the Oxford-AstraZeneca vaccine ‘Covishield’ A …

India’s Central Drugs Standard Control Organization (CDSCO) expert panel on Saturday recommended approving restricted emergency use of Bharat Biotech’s indigenous COVID vaccine Covaxin in India, said officials. Also read | …

The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech’s ‘Covaxin’ for emergency use in India. The final decision on its approval will, however, be …

Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on Vice-President M Venkaiah Naidu at his residence on Friday in Hyderabad. They discussed …

Hyderabad: Prominent drug firm Bharat Biotech has submitted the phase-2 study results of Covaxin in 380 participants and stated that the vaccine against Covid-19 has accelerated the response from immune …

The findings have appeared on medRxiv, a preprint server. A preprint is a version of a scientific manuscript posted on a public server prior to formal peer review COVAXIN vaccine …

COVID-19 vaccine Covaxin, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), was well tolerated in all dose groups with no serious or adverse …

Last week, Prime Minister Narendra Modi had said that a COVID-19 vaccine ‘may be ready in a few weeks’ at an all-party meeting COVAXIN vaccine by Bharath Biotech. New Delhi: After …

Chandigarh: Haryana Health Minister Anil Vij, who was administered the trial dose of the indigenous COVID vaccine Covaxin last month, has tested positive for coronavirus, he said in a tweet …

“The antibodies against the infection build up in a human being only after a specific number of days pass after the second dose of the vaccine is taken.” A little …

Meanwhile, world leaders, including the top leadership of the UN and vaccine developers, will address a two-day, special session of the UN General Assembly on COVID-19 this week Karnataka is …

The Phase-III clinical trial of Covid-19 vaccine (Covaxin) being developed by Bharat Biotech would begin at the privately-run Vydehi multi-specialty hospital here from Wednesday, an official said on Tuesday. “The …

The Phase-III clinical trial of Covid-19 vaccine (Covaxin) being developed by Bharat Biotech would begin at the privately-run Vydehi multi-specialty hospital here from Wednesday, an official said on Tuesday. “The …

Hyderabad: Prime Minister Narendra Modi will arrive in Hyderabad on Saturday to review the status of India’s first indigenous Covid-19 vaccine — Covaxin — being developed by the city-based Bharat …